ABOUT THE PROJECT
The International Esophageal Squamous Cell Carcinoma Consortium (IESC3) is a collaboration of research groups around the world that are leading large molecular, genetic and epidemiologic case control and cohort studies. The goals of the Consortium are to combine data from these international studies in order to gain greater ability to detect important risk factors of Esophageal Squamous Cell Carcinoma and to build a collaborative community of researchers dedicated to discovering what can be done to prevent it.
MISSION
The mission of the IESC3 is to reduce the occurrence and impact of esophageal squamous cell carcinoma in populations around the world by improving our understanding of what causes the disease.
NEWS
IESC3’s First General Meeting Highlights Global Collaboration in Esophageal Cancer Research
The International Esophageal Squamous Cell Carcinoma Consortium (IESC3) held its inaugural General Meeting on April 23, 2026, at the UCLA Fielding School of Public Health, bringing together leading researchers and clinicians from around the world to strengthen...
New International Consortium on Esophageal Squamous Cell Carcinoma Introduced at Leading Cancer meetings
The International Esophageal Squamous Cell Carcinoma Consortium (IESC3) was officially introduced during two major cancer research meetings held on May 14th and 15th, 2025. The consortium aims to unite researchers and studies worldwide to accelerate advancements in...